About Arthex Biotech
Arthex Biotech is a biotechnology company developing new treatments for diseases without many treatment options.
Arthex Biotech is running a clinical trial of an experimental medication called ATX-01 in participants with myotonic dystrophy type 1 (DM1).
The trial is called the ArthemiRTM trial.
